Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Schwarcz

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Tryptophan Research : IJTR|November 16, 2011
Paolo guidettiRobert Schwarcz
Current Opinion in Pharmacology|March 17, 2004
The kynurenine pathway of tryptophan degradation as a drug targetRobert Schwarcz
Epilepsia|March 8, 2008
Early glial dysfunction in epilepsyRobert Schwarcz
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunitiesRobert Schwarcz, Roberto Pellicciari
Brain Research. Molecular Brain Research|October 16, 2003
Determination of alpha-aminoadipic acid in brain, peripheral tissues, and body fluids using GC/MS with negative chemical ionizationPaolo Guidetti, Robert Schwarcz
Advances in Experimental Medicine and Biology|June 23, 2004
3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease?Paolo Guidetti, Robert Schwarcz
Schizophrenia Bulletin|February 12, 2010
Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in SchizophreniaIkwunga Wonodi, Robert Schwarcz
Facial Plastic Surgery Clinics of North America|November 7, 2025
Lateral Canthal Management in Esthetic Blepharoplasty, an UpdateErik Peterson, Robert Schwarcz
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 2011
Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitroErin K Stachowski, Robert Schwarcz
Biological Psychiatry|December 15, 2010
α7 Nicotinic receptor agonists as cognitive treatments: is less (or less often) more?Robert W Buchanan, Robert Schwarcz
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Tryptophan Research : IJTR|November 16, 2011
Paolo guidettiRobert Schwarcz
Current Opinion in Pharmacology|March 17, 2004
The kynurenine pathway of tryptophan degradation as a drug targetRobert Schwarcz
Epilepsia|March 8, 2008
Early glial dysfunction in epilepsyRobert Schwarcz
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunitiesRobert Schwarcz, Roberto Pellicciari
Brain Research. Molecular Brain Research|October 16, 2003
Determination of alpha-aminoadipic acid in brain, peripheral tissues, and body fluids using GC/MS with negative chemical ionizationPaolo Guidetti, Robert Schwarcz
Advances in Experimental Medicine and Biology|June 23, 2004
3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease?Paolo Guidetti, Robert Schwarcz
Schizophrenia Bulletin|February 12, 2010
Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in SchizophreniaIkwunga Wonodi, Robert Schwarcz
Facial Plastic Surgery Clinics of North America|November 7, 2025
Lateral Canthal Management in Esthetic Blepharoplasty, an UpdateErik Peterson, Robert Schwarcz
Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 2011
Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitroErin K Stachowski, Robert Schwarcz
Biological Psychiatry|December 15, 2010
α7 Nicotinic receptor agonists as cognitive treatments: is less (or less often) more?Robert W Buchanan, Robert Schwarcz
Pageof 14